Cannabinoids in glioblastoma multiforme—hype or hope?
Open Access
- 24 February 2021
- journal article
- editorial
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 124 (8), 1341-1343
- https://doi.org/10.1038/s41416-021-01265-5
Abstract
Cannabis and its derivatives are being used increasingly by patients with cancer, including patients with glioblastoma multiforme (GBM), the most common and aggressive primary brain malignancy. Despite promising preclinical data suggesting potential anti-cancer effects for cannabinoids in GBM, clinical and safety data are lacking. This editorial will discuss a recent Phase 1b trial of nabiximols oromucosal spray in combination with dose-intense temozolomide in patients with recurrent GBM in the context of other relevant findings in this field.Keywords
This publication has 14 references indexed in Scilit:
- EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthoodNature Reviews Clinical Oncology, 2020
- Cannabis and its constituents for cancer: History, biogenesis, chemistry and pharmacological activitiesPharmacological Research, 2020
- The pharmacological basis for application of cannabidiol in cancer chemotherapyPharmacia, 2020
- RETRACTED ARTICLE: Inhibition of autophagic flux differently modulates cannabidiol-induced death in 2D and 3D glioblastoma cell culturesScientific Reports, 2020
- Concomitant Treatment of Malignant Brain Tumours With CBD – A Case Series and Review of the LiteratureAnticancer Research, 2019
- Optimization of a preclinical therapy of cannabinoids in combination with temozolomide against gliomaBiochemical Pharmacology, 2018
- The current state and future perspectives of cannabinoids in cancer biologyCancer Medicine, 2018
- A Combined Preclinical Therapy of Cannabinoids and Temozolomide against GliomaMolecular Cancer Therapeutics, 2011
- Distinctive pattern of cannabinoid receptor type II (CB2) expression in adult and pediatric brain tumorsBrain Research, 2007
- A pilot clinical study of Δ9-tetrahydrocannabinol in patients with recurrent glioblastoma multiformeBritish Journal of Cancer, 2006